Vanessa Armendariz, MD
Family Practice · Stockton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 6 years
- University of Kansas School of Med (Kc/Wich/Sal), 2020
Offices
3 locations · Community Medical Centers, Inc. · 47 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Armendariz’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A185358 · Current
Licensed to practise in California · since 2023 · expires 2027-06-30 · University of Kansas School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
Medicaid work
$210,794 in 2024
Medicaid paid $210,794 for 6,158 billed services this clinician did in 2024, up to 159 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,473 | $210,634 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 260 | $152 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 303 | $5 |
| HEMOGLOBIN | 101 | $4 |
| Subsequent prenatal care visit (Prenatal) [Excludes: patients who are seen for a condition unrelated to pregnancy or prenatal care (eg, an upper respiratory infection; patients seen for consultation only, not for continuing care)] | 54 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 973 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 86 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 873 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 272 | $0 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 270 | $0 |
| URINE PREGNANCY TEST | 48 | $0 |
| Blood glucose (sugar) level | 128 | $0 |
| 2024 | 6,158 | 17 | 159 | $210,794 |
| 2023 | 1,868 | 10 | 83 | $98,197 |
| 2022 | 24 | 1 | 23 | $190 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 600 | $97,767 |
| Short return visit (20+ min) | 240 | $326 |
| Short return visit | 12 | $54 |
| Return visit (30+ min) | 294 | $49 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 294 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 262 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 29 | $0 |
| Blood glucose (sugar) level | 15 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 29 | $0 |
| Brief emotional/behavioral assessment (eg, depression inventory, attention-deficit/hyperactivity disorder [ADHD] scale), with scoring and documentation, per standardized instrument | 93 | $0 |
2022
| Short return visit (20+ min) | 24 | $190 |
Drugs they prescribed that Part D paid
$132,537
Pharmacies billed $132,537 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (12 of 785) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
619 generic and fewer than 11 brand-name prescriptions · $132,537 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 27 | $27,983 | $1,036 |
| Synjardy | 35 | $24,177 | $691 |
| Ozempic | 11 | $9,158 | $833 |
| Lantus Solostar | 15 | $790 | $53 |
| Atorvastatin | 84 | $520 | $6 |
See all 16 drugs
| Jardiance | 27 | $27,983 | $1,036 |
| Synjardy | 35 | $24,177 | $691 |
| Ozempic | 11 | $9,158 | $833 |
| Lantus Solostar | 15 | $790 | $53 |
| Atorvastatin | 84 | $520 | $6 |
| Losartan | 55 | $334 | $6 |
| Amlodipine Besylate | 50 | $197 | $4 |
| Losartan-Hydrochlorothiazide | 13 | $189 | $15 |
| Tamsulosin | 15 | $179 | $12 |
| Simvastatin | 21 | $165 | $8 |
| Metformin | 24 | $109 | $5 |
| Lisinopril | 35 | $103 | $3 |
| Hydrochlorothiazide | 16 | $73 | $5 |
| Lisinopril-Hydrochlorothiazide | 20 | $69 | $3 |
| Famotidine | 14 | $65 | $5 |
| Alendronate | 13 | $24 | $2 |
Year by year
| 2024 | 785 | 130 | 2% (12) | None | $132,537 |
| 2023 | 334 | 76 | 3% (11) | 13% | $45,727 |
| 2022 | 330 | 41 | 5% (15) | 14% | $36,855 |
| 2021 | 298 | 30 | None | None | $37,894 |
| 2020 | 48 | None | 0% (0) | None | $4,119 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Atorvastatin | 23 | $806 | $35 |
| Tamsulosin | 11 | $395 | $36 |
| Amlodipine Besylate | 15 | $227 | $15 |
| Lisinopril | 19 | $166 | $9 |
| Simvastatin | 13 | $53 | $4 |
2022: 7 drugs
| Jardiance | 15 | $14,095 | $940 |
| Atorvastatin | 27 | $588 | $22 |
| Levothyroxine | 23 | $412 | $18 |
| Bupropion Xl | 14 | $287 | $21 |
| Duloxetine | 11 | $242 | $22 |
| Lisinopril | 13 | $78 | $6 |
| Clonazepam | 15 | $37 | $2 |
2021: 4 drugs
| Atorvastatin | 28 | $659 | $24 |
| Levothyroxine | 18 | $169 | $9 |
| Lisinopril | 19 | $79 | $4 |
| Metformin | 16 | $41 | $3 |
Money from drug and device companies
$260 in 2025
| 2025 | 3 | 4 | None | $260 |
| 2024 | 2 | 3 | None | $212 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Mavyret | $129 | 2 payments
|
| Lilly USA | Zepbound | $109 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $21 | 1 payment
|
See all 4 published payments
| Lilly USA | Meals · 2025-09-17 | Zepbound | $109 |
| Exact Sciences | Meals · 2025-08-08 | Cologuard Collection Kit | $21 |
| Abbvie | Meals · 2025-05-08 | Mavyret | $101 |
| Abbvie | Meals · 2025-01-08 | Mavyret | $28 |
See earlier years (2024)
2024: $212
| Abbvie | Mavyret | $106 | 2 payments
|
| Dexcom | Dexcom G6 Transmitter | $106 | 1 payment
|
Professional record
- NPI
- 1972130573
- Licence
- CA A185358California A185358: Current · expires 2027-06-30
- Trained
- University of Kansas School of Med (Kc/Wich/Sal), 2020 · 6 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 701 E Channel St, Stockton, CA, 95202
- NPI first listed
- 2020-03-24
- NPI last updated
- 2023-08-01
- NPI record certified
- 2023-05-02
This is when the NPI record was last certified, not a medical board exam.